← Back to Search

Polycyclic Aromatic Hydrocarbon

[14C]-benzo[a]pyrene for Environmental Exposures

Phase < 1
Waitlist Available
Research Sponsored by Oregon State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 hours
Awards & highlights

Summary

This trial is evaluating how the body processes a small amount of a chemical called benzo[a]pyrene, given four times at different doses.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 48 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Plasma and urine benzo[a]pyrene and metabolite levels after oral dose
Secondary outcome measures
Area under plasma concentration versus time curve AUC
Metabolites in plasma
Metabolites in urine
+3 more

Trial Design

4Treatment groups
Experimental Treatment
Group I: 50 ng doseExperimental Treatment1 Intervention
Capsule containing 50 ng (2.7 nCi) [14C]-benzo[a]pyrene (BaP)
Group II: 250 ng doseExperimental Treatment1 Intervention
Capsule containing 100 ng (2.7 nCi) [14C]-benzo[a]pyrene (BaP)
Group III: 25 ng doseExperimental Treatment1 Intervention
Capsule containing 25 ng (2.7 nCi) [14C]-benzo[a]pyrene (BaP)
Group IV: 100 ng doseExperimental Treatment1 Intervention
Capsule containing 100 ng (2.7 nCi) [14C]-benzo[a]pyrene (BaP)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
[14C]-benzo[a]pyrene
2018
Completed Early Phase 1
~20

Find a Location

Who is running the clinical trial?

Oregon State UniversityLead Sponsor
50 Previous Clinical Trials
8,438 Total Patients Enrolled
3 Trials studying Environmental Exposures
452 Patients Enrolled for Environmental Exposures
National Institute of Environmental Health Sciences (NIEHS)NIH
286 Previous Clinical Trials
1,232,645 Total Patients Enrolled
12 Trials studying Environmental Exposures
4,758 Patients Enrolled for Environmental Exposures
Pacific Northwest National LaboratoryFED
9 Previous Clinical Trials
3,768 Total Patients Enrolled
2 Trials studying Environmental Exposures
12 Patients Enrolled for Environmental Exposures

Media Library

Benzo[a]Pyrene (Polycyclic Aromatic Hydrocarbon) Clinical Trial Eligibility Overview. Trial Name: NCT03318978 — Phase < 1
Environmental Exposures Research Study Groups: 100 ng dose, 25 ng dose, 250 ng dose, 50 ng dose
Environmental Exposures Clinical Trial 2023: Benzo[a]Pyrene Highlights & Side Effects. Trial Name: NCT03318978 — Phase < 1
Benzo[a]Pyrene (Polycyclic Aromatic Hydrocarbon) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03318978 — Phase < 1
~1 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top